Appraisal of exercise recommendations for osteoporosis treatment of current guidelines: a systematic review

Regil-González, Paulina De; León, Andrea Olascoaga-Gómez de; Chávez-Arias, Daniel D.; Nava‐Bringas, Tania Inés; Macías‐Hernández, Salvador Israel; Cruz‐Medina, Eva; Lara-Vázquez, Blanca Isabel; Coronado‐Zarco, Roberto

doi:10.15174/au.2015.767

Cited by 3 publications

(3 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The benefits of exercise are related to reduction of fall risk. There are many conditions that shall be taken in consideration when prescribing exercise for osteoporosis, like comorbidities [88]. Besides, there is little information on CPG related to prescription of exercise by means of type, intensity, duration and frequency.…”

Section: Discussionmentioning

confidence: 99%

Nonpharmacological interventions for osteoporosis treatment: Systematic review of clinical practice guidelines

Coronado‐Zarco

León

García-Lara

et al. 2019

Osteoporosis and Sarcopenia

View full text Add to dashboard Cite

ObjectivesThe aim of this study was to perform a systematic review of clinical practice guidelines to identify nonpharmacologic recommendations for osteoporosis treatment.MethodsA systematic review of literature following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)-statement methodology for clinical practice guidelines was conducted; PROSPERO CRD42019138548. Assessment of selected clinical practice guidelines with the AGREE (Appraisal of Guidelines for Research & Evaluation)-II methodological quality instrument was performed, and those graded over 60 points were selected for recommendations extraction and evidence analysis.ResultsOnly 6 clinical practice guidelines fulfilled criteria, 69 nonpharmacological recommendations were extracted: 13 from American Association of Clinical Endocrinologists and American College of Endocrinology guideline, 16 from Malaysian Osteoporosis Society guideline, 15 from the Ministry of Health in Mexico guideline, 14 from Royal Australian College of General Practitioners guideline, 7 from Sociedad Española de Investigación Ósea y del Metabolismo Mineral guideline, and 7 from National Osteoporosis Guideline Group guideline. Percentage by theme showed that the highest number of recommendations were 12 (17.1%) for vitamin D, 11 (15.7%) for a combination of calcium and vitamin D, and 11 (15.7%) for exercise.ConclusionsThese recommendations address integrating interventions to modify lifestyle, mainly calcium and vitamin D intake, and exercise. Other recommendations include maintaining adequate protein intake, identification and treatment of risk factors for falls, and limiting the consumption of coffee, alcohol and tobacco. Considerations on prescription must be taken.

show abstract

Section: Discussionmentioning

confidence: 99%

Nonpharmacological interventions for osteoporosis treatment: Systematic review of clinical practice guidelines

Coronado‐Zarco

León

García-Lara

et al. 2019

Osteoporosis and Sarcopenia

View full text Add to dashboard Cite

show abstract

“…The studies have shown that high-impact and weight-bearing exercises are primarily important for increasing the bone mass. Another factor that could be effective in increasing BMD is the muscle power output during the exercise and increase of muscle strength over time [63,64]. This could be due to the fact that the force exerted by the muscle on the bone could stimulate the bone formation and increase of BMD.…”

Section: Discussionmentioning

confidence: 99%

Body composition and lipid profile of regular recreational table tennis participants: a cross-sectional study of older adult men

et al. 2018

View full text Add to dashboard Cite

The aim of the present study was to investigate the effects of regular participation in recreational table tennis training on bone health, body composition and lipid profile of elderly men. 20 regular recreational table tennis players (11.6 ± 3.6 years of experience) and 20 sedentary older adults (age, mass and sex matched of 65-75 years) participated in the study. Serum triglycerides, total cholesterol, HDL-cholesterol, and LDL-cholesterol concentrations were determined after 12 h fasting. Body composition was analyzed using dual-energy X-ray absorptiometry. Regular recreational table tennis participants displayed higher HDL-cholesterol (p = 0.03) and lower LDL-cholesterol (p = 0.04) and triglycerides (p = 0.002) compared to sedentary participants. In the regular recreational table tennis participants compared with sedentary participants, total (p = 0.001), sub-regional [lumbar spines (p = 0.001), arm (p = 0.006), leg (p < 0.008)] and site-specific [femoral neck (p = 0.007), trochanter (p = 0.03), and ward's triangle (p = 0.001)] bone mineral densities were higher. Body fat percentage (p = 0.04) and total and sub-regional fat mass [arm (p = 0.004), leg (p = 0.02), and trunk (p = 0.04)] were lower. There was no significant difference in the total and sub-regional lean mass between groups (p > 0.05). This study offers preliminary evidence to suggest that recreational table tennis training, with the potential for permanent implementation, is associated with beneficial effects on body composition and lipid profile in older adult men. Further research regarding recreational table tennis to be used as a health-promoting activity for older adults is warranted.

show abstract

“…Individuals with MBD should be educated about the potential advantages of physical activity and motivated to be active within their ability and in keeping their values and goals as realistically possible. They should be given training on how to self-monitor for signs and symptoms that should be brought to their healthcare team's attention and the emergency contact information for this team should be issued [16].…”

Section: Physical Activitymentioning

confidence: 99%

Calcium and Metabolic Bone Disorders

Ale¹,

Akande²,

Rocha-Afodu³

2021

Mineral Deficiencies - Electrolyte Disturbances, Genes, Diet and Disease Interface

View full text Add to dashboard Cite

Calcium homeostasis has a pivotal role in regulating many biological processes. The interplay of calcium-regulating hormones, including parathyroid hormone (PTH), vitamin D, and calcitonin, is crucial in tightly maintaining serum calcium levels. Deregulation of calcium homeostasis has clinical implications resulting in hypercalcemia or hypocalcemia, which can lead to metabolic bone disease (MBD). MBD is a group of multifactorial bone diseases, caused by bone demineralization and characterized by an increased susceptibility to fracture risk. This chapter aims to provide an overview of associated risk factors and diagnostic, prevention, and recent treatment methods for MBD. The diagnosis of MBD is based on the assessment of clinical signs, radiological findings, quantitative ultrasonography, and biochemical evaluation of serum calcium, phosphate, PTH, alkaline phosphatase, and vitamin D. Current pharmacological treatments include antiresorptive and anabolic conventional therapies. Additionally, the efficacy of herbal extracts and nutritional supplements have been evaluated. Recent advances in the MBD management include drugs targeting calcium-sensing receptor and parathyroid hormone-related proteins, leading to the development of cathepsin K and Src tyrosine kinase inhibitors, calcilytics, and monoclonal antibodies against sclerostin or Dickkopf-1. Moreover, new nanomaterials have been used for improving the surgical treatment of vertebral fractures.

show abstract

Appraisal of exercise recommendations for osteoporosis treatment of current guidelines: a systematic review

Cited by 3 publications

References 22 publications

Nonpharmacological interventions for osteoporosis treatment: Systematic review of clinical practice guidelines

Nonpharmacological interventions for osteoporosis treatment: Systematic review of clinical practice guidelines

Body composition and lipid profile of regular recreational table tennis participants: a cross-sectional study of older adult men

Calcium and Metabolic Bone Disorders

Contact Info

Product

Resources

About